It is expected that Glaxo Wellcome and SmithKline Beecham will complete their merger on Dec.27, 2000-nearly a year after unveiling their plans to become a conglomerate.
The British drug groups are waiting for approval of the deal from the US Federal Trade Commission (FTC) before going in front of Britain's High Court next week for final clearance.
GlaxoSmithKline would become the largest pharmaceutical company worldwide by market share, controlling more than 7% of the world market. The first financial results to be reported by GlaxoSmithKline will be for the year ending Dec. 31 and will be announced in February.
The merger was expected to be complete last May; however, the FTC had questions about the companies' combined power in certain markets.
Information from The Wall Street Journal.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.